扩大麻醉儿科等研究生招生规模、评职称强调临床实践……医学人才培养新变化!

2020-10-07 中国政府网 中国政府网

李克强总理近日主持召开国务院常务会议,部署加快医学教育创新发展,为维护人民健康提供人才保障。李克强说,我国医护人才总量、结构都还不适应健康中国建设需要。此次疫情更加显现出公共卫生、重症救治和护理等方面

李克强总理近日主持召开国务院常务会议,部署加快医学教育创新发展,为维护人民健康提供人才保障。李克强说,我国医护人才总量、结构都还不适应健康中国建设需要。此次疫情更加显现出公共卫生、重症救治和护理等方面人才不足。要加大医学教育改革创新力度,增强医护人才保障。

日前,国务院办公厅印发《关于加快医学教育创新发展的指导意见》,加快医学教育创新发展、培养高质量医学人才上,有什么最新安排?一起来看——

招生上——

新增招生计划重点向紧缺人才倾斜!

严格控制高职(专科)临床医学类专业招生规模,大力发展高职护理专业教育,加大护理专业人才供给。

稳步发展本科临床医学类、中医学类专业教育。

适度扩大研究生招生规模,调整研究生招生结构,新增招生计划重点向紧缺人才倾斜。

提高入口生源质量。积极采取措施吸引优质生源报考医学专业。

坚持以需定招,合理确定招生结构和规模。

在基础学科招生改革试点工作中加大对医学人才培养支持力度,将基础医学等医学学科纳入改革试点。研究将护理(学)专业纳入国家控制布点专业。

培养阵地上——

推进医学生早临床、多临床、反复临床!

夯实高校附属医院医学人才培养主阵地。高校附属医院要健全临床教学组织机构、稳定教学管理队伍,设立专门的教学门诊和教学病床,着力推进医学生早临床、多临床、反复临床。

系统推进综合性大学医学教育统筹管理。实化医学院(部)职能,完善大学、医学院(部)、附属医院医学教育管理运行机制,保障医学教育的完整性。

学科建设上——

加强麻醉、感染、重症学科建设!

在一流大学和一流学科建设中,加大医学及相关学科建设布局和支持力度。

2020年临床医学博士专业学位授权单位均须设置麻醉、感染、重症、儿科学科,大幅度扩大麻醉、感染、重症、儿科研究生招生规模。

优化学科结构,2021年完成医学二级学科目录编制调整,将麻醉、感染、重症学科纳入临床医学指导性二级学科目录并加大建设力度。统筹研究医学相关一级学科设置。

修订临床医学博士、硕士研究生培养方案,加强麻醉、感染、重症学科研究生课程建设,强化实践能力和科研思维能力培养。

人才培养上——

深化住院医师培训和继续医学教育改革!

全科医学人才:逐步扩大订单定向免费医学生培养规模,中央财政继续支持为中西部乡镇卫生院培养本科定向医学生。系统规划全科医学教学体系,3年内推动医学院校普遍成立全科医学教学组织机构,加强面向全体医学生的全科医学教育。

高水平公共卫生人才:加大高层次专业人才供给,将公共卫生与预防医学相关学科专业纳入“国家关键领域急需高层次人才培养专项招生计划”支持范围,增加专项研究生招生计划数量。

高层次复合型医学人才:设置交叉学科,促进医工、医理、医文学科交叉融合。推进“医学+X”多学科背景的复合型创新拔尖人才培养。

中西医结合人才:试点开展九年制中西医结合教育,培养少而精、高层次、高水平的中西医结合人才。

住院医师:夯实住院医师医学理论基础,强化临床思维、临床实践能力培养。加大全科等紧缺专业住院医师培训力度。保障住院医师合理待遇,鼓励承担培训任务的公立医疗卫生机构对全科、儿科等紧缺专业培训对象的薪酬待遇予以倾斜。对经住培合格的本科学历临床医师,在人员招聘、职称晋升、岗位聘用、薪酬待遇等方面,与临床医学、中医专业学位硕士研究生同等对待。

推进继续医学教育创新发展。大力发展远程教育。保证所有在职在岗医务人员接受继续教育和职业再培训。在卫生专业技术人员职称评价中,突出品德、能力、业绩导向,强调临床实践等业务工作能力,破除唯论文倾向。

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1926122, encodeId=3dc619261225a, content=<a href='/topic/show?id=a2973401047' target=_blank style='color:#2F92EE;'>#医学人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34010, encryptionId=a2973401047, topicName=医学人才)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Sun Feb 21 04:25:56 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900278, encodeId=0f0119002e8db, content=<a href='/topic/show?id=a0cfe3416be' target=_blank style='color:#2F92EE;'>#研究生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73416, encryptionId=a0cfe3416be, topicName=研究生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Fri Jul 02 16:25:56 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642563, encodeId=e4e7164256384, content=<a href='/topic/show?id=12f456241f6' target=_blank style='color:#2F92EE;'>#招生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56241, encryptionId=12f456241f6, topicName=招生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b6e22960106, createdName=12498e87m46暂无昵称, createdTime=Wed Jul 28 22:25:56 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272765, encodeId=b9ee12e276503, content=<a href='/topic/show?id=d04f440581e' target=_blank style='color:#2F92EE;'>#大麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44058, encryptionId=d04f440581e, topicName=大麻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324462, encodeId=33f41324462a5, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518345, encodeId=0059151834579, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554894, encodeId=05e3155489422, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1926122, encodeId=3dc619261225a, content=<a href='/topic/show?id=a2973401047' target=_blank style='color:#2F92EE;'>#医学人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34010, encryptionId=a2973401047, topicName=医学人才)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Sun Feb 21 04:25:56 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900278, encodeId=0f0119002e8db, content=<a href='/topic/show?id=a0cfe3416be' target=_blank style='color:#2F92EE;'>#研究生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73416, encryptionId=a0cfe3416be, topicName=研究生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Fri Jul 02 16:25:56 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642563, encodeId=e4e7164256384, content=<a href='/topic/show?id=12f456241f6' target=_blank style='color:#2F92EE;'>#招生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56241, encryptionId=12f456241f6, topicName=招生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b6e22960106, createdName=12498e87m46暂无昵称, createdTime=Wed Jul 28 22:25:56 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272765, encodeId=b9ee12e276503, content=<a href='/topic/show?id=d04f440581e' target=_blank style='color:#2F92EE;'>#大麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44058, encryptionId=d04f440581e, topicName=大麻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324462, encodeId=33f41324462a5, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518345, encodeId=0059151834579, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554894, encodeId=05e3155489422, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1926122, encodeId=3dc619261225a, content=<a href='/topic/show?id=a2973401047' target=_blank style='color:#2F92EE;'>#医学人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34010, encryptionId=a2973401047, topicName=医学人才)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Sun Feb 21 04:25:56 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900278, encodeId=0f0119002e8db, content=<a href='/topic/show?id=a0cfe3416be' target=_blank style='color:#2F92EE;'>#研究生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73416, encryptionId=a0cfe3416be, topicName=研究生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Fri Jul 02 16:25:56 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642563, encodeId=e4e7164256384, content=<a href='/topic/show?id=12f456241f6' target=_blank style='color:#2F92EE;'>#招生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56241, encryptionId=12f456241f6, topicName=招生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b6e22960106, createdName=12498e87m46暂无昵称, createdTime=Wed Jul 28 22:25:56 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272765, encodeId=b9ee12e276503, content=<a href='/topic/show?id=d04f440581e' target=_blank style='color:#2F92EE;'>#大麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44058, encryptionId=d04f440581e, topicName=大麻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324462, encodeId=33f41324462a5, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518345, encodeId=0059151834579, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554894, encodeId=05e3155489422, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1926122, encodeId=3dc619261225a, content=<a href='/topic/show?id=a2973401047' target=_blank style='color:#2F92EE;'>#医学人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34010, encryptionId=a2973401047, topicName=医学人才)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Sun Feb 21 04:25:56 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900278, encodeId=0f0119002e8db, content=<a href='/topic/show?id=a0cfe3416be' target=_blank style='color:#2F92EE;'>#研究生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73416, encryptionId=a0cfe3416be, topicName=研究生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Fri Jul 02 16:25:56 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642563, encodeId=e4e7164256384, content=<a href='/topic/show?id=12f456241f6' target=_blank style='color:#2F92EE;'>#招生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56241, encryptionId=12f456241f6, topicName=招生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b6e22960106, createdName=12498e87m46暂无昵称, createdTime=Wed Jul 28 22:25:56 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272765, encodeId=b9ee12e276503, content=<a href='/topic/show?id=d04f440581e' target=_blank style='color:#2F92EE;'>#大麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44058, encryptionId=d04f440581e, topicName=大麻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324462, encodeId=33f41324462a5, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518345, encodeId=0059151834579, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554894, encodeId=05e3155489422, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1926122, encodeId=3dc619261225a, content=<a href='/topic/show?id=a2973401047' target=_blank style='color:#2F92EE;'>#医学人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34010, encryptionId=a2973401047, topicName=医学人才)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Sun Feb 21 04:25:56 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900278, encodeId=0f0119002e8db, content=<a href='/topic/show?id=a0cfe3416be' target=_blank style='color:#2F92EE;'>#研究生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73416, encryptionId=a0cfe3416be, topicName=研究生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Fri Jul 02 16:25:56 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642563, encodeId=e4e7164256384, content=<a href='/topic/show?id=12f456241f6' target=_blank style='color:#2F92EE;'>#招生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56241, encryptionId=12f456241f6, topicName=招生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b6e22960106, createdName=12498e87m46暂无昵称, createdTime=Wed Jul 28 22:25:56 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272765, encodeId=b9ee12e276503, content=<a href='/topic/show?id=d04f440581e' target=_blank style='color:#2F92EE;'>#大麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44058, encryptionId=d04f440581e, topicName=大麻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324462, encodeId=33f41324462a5, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518345, encodeId=0059151834579, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554894, encodeId=05e3155489422, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1926122, encodeId=3dc619261225a, content=<a href='/topic/show?id=a2973401047' target=_blank style='color:#2F92EE;'>#医学人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34010, encryptionId=a2973401047, topicName=医学人才)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Sun Feb 21 04:25:56 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900278, encodeId=0f0119002e8db, content=<a href='/topic/show?id=a0cfe3416be' target=_blank style='color:#2F92EE;'>#研究生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73416, encryptionId=a0cfe3416be, topicName=研究生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Fri Jul 02 16:25:56 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642563, encodeId=e4e7164256384, content=<a href='/topic/show?id=12f456241f6' target=_blank style='color:#2F92EE;'>#招生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56241, encryptionId=12f456241f6, topicName=招生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b6e22960106, createdName=12498e87m46暂无昵称, createdTime=Wed Jul 28 22:25:56 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272765, encodeId=b9ee12e276503, content=<a href='/topic/show?id=d04f440581e' target=_blank style='color:#2F92EE;'>#大麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44058, encryptionId=d04f440581e, topicName=大麻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324462, encodeId=33f41324462a5, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518345, encodeId=0059151834579, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554894, encodeId=05e3155489422, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=)]
    2020-10-09 xxxx1053
  7. [GetPortalCommentsPageByObjectIdResponse(id=1926122, encodeId=3dc619261225a, content=<a href='/topic/show?id=a2973401047' target=_blank style='color:#2F92EE;'>#医学人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34010, encryptionId=a2973401047, topicName=医学人才)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Sun Feb 21 04:25:56 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900278, encodeId=0f0119002e8db, content=<a href='/topic/show?id=a0cfe3416be' target=_blank style='color:#2F92EE;'>#研究生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73416, encryptionId=a0cfe3416be, topicName=研究生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Fri Jul 02 16:25:56 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642563, encodeId=e4e7164256384, content=<a href='/topic/show?id=12f456241f6' target=_blank style='color:#2F92EE;'>#招生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56241, encryptionId=12f456241f6, topicName=招生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b6e22960106, createdName=12498e87m46暂无昵称, createdTime=Wed Jul 28 22:25:56 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272765, encodeId=b9ee12e276503, content=<a href='/topic/show?id=d04f440581e' target=_blank style='color:#2F92EE;'>#大麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44058, encryptionId=d04f440581e, topicName=大麻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324462, encodeId=33f41324462a5, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518345, encodeId=0059151834579, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554894, encodeId=05e3155489422, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Fri Oct 09 14:25:56 CST 2020, time=2020-10-09, status=1, ipAttribution=)]

相关资讯

李克强:推进突出临床实践的职称评定

9月9日,第36个教师节前夕,李克强总理主持召开国务院常务会议,决定开展以能力为导向的考试评价改革,推进突出临床实践的职称评定。

从临床证据到临床实践,畅谈奥希替尼一线治疗

FLAURA研究显示,在EGFR突变阳性晚期非小细胞肺癌(NSCLC)一线治疗中,与标准EGFR-TKI(厄洛替尼或吉非替尼)10.2个月的中位无进展生存(PFS)相比,奥希替尼组中位PFS达到前所未有的18.9个月。基于这一研究结果,奥希替尼获批用于一线治疗,且越来越多的临床指南推荐其作为EGFR敏感突变NSCLC的一线优选方案。今年ESMO年会上,FLAURA研究的OS结果即将公布,并有望取得

Lancet:科学家建议将新分子成像技术应用于侵袭性癌症常规检查

科学家建议把比传统成像更准确的分子成像技术引入常规临床实践。

KEYNOTE-062引发的关于免疫治疗研究与临床实践的深度思考

北京消化肿瘤国际高峰论坛暨中国胃肠肿瘤临床研究协作组年会在北京隆重召开。北京大学肿瘤医院的沈琳教授担任大会主席,国内外学术领军人物济济一堂,就胃肠道肿瘤临床和转化研究的瓶颈、挑战及突破进行了深入的交流、研讨和展望。大会设有多个分会场,在食管癌/胃癌专场,来自北京大学肿瘤医院的张小田教授就“2019年ASCO胃癌研究进展”发表主题演讲,张教授的演讲中特别介绍了近来热议的KEYNOTE-062研究,这

直击ABC5:Eric P. Winer教授专访:新的研究成果改变进展期乳腺癌临床实践

ESO-ESMO 晚期乳腺癌第 5 届国际共识大会 (ABC5)在葡萄牙里斯本举行,该会议专注晚期乳腺癌诊疗进展并每2年更新一次指南。本次会议期间,肿瘤资讯非常荣幸邀请到乳腺癌治疗领域的世界级专家、丹娜法伯癌症研究所的Eric Paul Winer教授,Winer教授简要阐述了《ESO-ESMO晚期乳腺癌国际共识》与其他指南的不同之处,着力介绍了CDK4/6抑制剂、免疫治疗与TDM1三种治疗方法将

PACIFIC研究影响NSCLC免疫治疗临床实践,获益或不止步于Ⅲ期患者

Ⅲ期非小细胞肺癌(NSCLC)患者数量庞大,占所有NSCLC患者人数的1/3左右,其诊断相对复杂,治疗方式也多种多样。Ⅲ期不可手术NSCLC的5年生存率为约20%左右,其标准治疗为以铂类药物为基础的同步放化疗,然而在相当长一段时间内,大多数患者的临床结局未得到改善。PACIFIC研究的成功,打破了治疗的困局。广东省人民医院的乔贵宾教授对Ⅲ期NSCLC诊疗现状和免疫治疗临床实践等热点问题进行解读。